Rx Price Reduction Act: Combating Unfair International Drug Pricing
This act aims to ensure Americans don't bear disproportionately high costs for new drug development. It establishes a new trade negotiator role to combat countries artificially lowering drug prices, protecting access to innovative therapies and potentially lowering costs for US patients.
Key points
Establishes a Chief Pharmaceutical Trade Negotiator to advocate for US pharmaceutical manufacturers and consumers.
Requires annual reports on high-income countries with unfair pharmaceutical trade practices, allowing for responsive actions.
Aims to ensure other countries pay their fair share for new drug development, potentially impacting drug availability and prices in the US.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.